NCT03956316

Brief Summary

The goals of total, reverse total and hemi shoulder arthroplasty are the same, to alleviate the patient's pain and obtain a full functional recovery. This outcome depends on the surgeon's ability to reproduce normal glenohumeral anatomy including bone morphology, capsular tension and rotator cuff function. Shoulder arthroplasty has become a safe and effective treatment for various diseases of the shoulder. This study goal is to document and report the short-term functional, radiographic, and quality of life outcomes of total shoulder arthroplasty (TSA) using the titan modular shoulder system.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2014

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2014

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 22, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 22, 2015

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

April 10, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 20, 2019

Completed
Last Updated

May 20, 2019

Status Verified

May 1, 2019

Enrollment Period

1.2 years

First QC Date

April 10, 2019

Last Update Submit

May 17, 2019

Conditions

Outcome Measures

Primary Outcomes (6)

  • ASES

    1\. ASES: the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment 1. The ASES scale is intended to measure functional limitations and pain of the shoulder. 2. ASES is a 0 - 100 point scale; higher scores indicate better outcomes. i. The ASES consists of two dimensions: pain and function (worth 50 points each). a. The ASES questionnaire is composed of both a physician-rated component and a patient-reported component. Patient questions focus on: joint pain, instability and activities of daily living. Physician questions focus on: range of motion, strength, signs and instability

    two year post op

  • EQ-5D-5L

    2\. EQ5D-5L: EuroQuol-5D a. The EQ5D-5L scale evaluates general health status. The EQ-5D-5L has two sections; the first section measures health status using a descriptive system (index of 5 scores) and the second section measures health status on a Visual Analog Scale. i. The EQ-5D-5L VAS outcome is measured on a 0 - 100 point scale. Optimal health status is indicated with a score of 100. ii. The EQ-5D-5L descriptive system consists of 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is evaluated with a score of 1-5, higher scores indicate worse outcomes. 1\. On each dimension, a score of 1 indicates no patient problems in that dimension, 2 indicates slight problems in that dimension, 3 indicates moderate problems in that dimension, 4 indicates severe problems in that dimension and 5 indicates extreme problems in that dimension.

    two year post op

  • PENN

    3\. PENN: PENN Shoulder Score 1. The PENN Shoulder Score is used to assess patient self-reported levels of pain, satisfaction and function. 2. PENN is measured on a 0 - 100 point scale; higher scores indicate better outcomes. 3. The PENN consists of 3 subscales: pain (at rest, with activity, and with strenuous activity), satisfaction and function. The PENN Pain subscale is scored from 0 to 30, the PENN satisfaction subscale is scored from 0 to 10 and the PENN function subscale is scored from 0 to 60.

    two year post op

  • SANE

    4\. SANE: Single assessment numeric evaluation 1. SANE is an outcome scale used to record the patient's self-reported function. 2. SANE is implemented on a scale of 0 - 100, 100 indicates full function (or function prior to injury) and 0 represents no function.

    two year post op

  • CS

    5\. CS: Constant-Murley Score 1. The CS score assesses functionality after the treatment of a shoulder injury. 2. CS is measured on a 0 - 100 point scale. Higher scores indicate better shoulder function. 3. CS is composed of four subscales: pain (15 points, based on patient report), activities of daily living (20 points, based on patient report), strength (25 points), and range of motion (40 points).

    two year post op

  • WOOS

    6\. WOOS: Western Ontario Osteoarthritis of the Shoulder index 1. WOOS is a disease-specific quality of life PRO tool, developed for osteoarthritis. 2. WOOS is measured on a 0-1900 point scale; 1900 indicates a clinical outcome fully symptomatic of osteoarthritis and 0 indicates an asymptomatic outcome. i. WOOS is composed of 19 items scored on 100-point VAS scales. The 19 items represent four domains (6 questions for pain and physical symptoms, 5 questions for sport/recreation/work function, 5 questions for lifestyle function and 3 questions for emotional function).

    two year post op

Interventions

total shoulder arthroplasty using the Titan Modular Total Shoulder System

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

39 subjects received total shoulder arthroplasty using the Titan Modular Total Shoulder System. 25 subjects agreed to participate in the study.

You may qualify if:

  • Total shoulder arthroplasty using the Titan Modular Total Shoulder System

You may not qualify if:

  • Declining to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 10, 2019

First Posted

May 20, 2019

Study Start

October 15, 2014

Primary Completion

December 22, 2015

Study Completion

December 22, 2015

Last Updated

May 20, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Data will not be shared.